T. Rowe Price Associates’s RAPT Therapeutics RAPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-21,972	Closed	-$355K	–	3050
2024 Q3	$355K	Sell	21,972 -4,090	-16%	-$82.7K	﹤0.01%	2404
2024 Q2	$637K	Sell	26,062 -227,459	-90%	-$10.5M	﹤0.01%	2092
2024 Q1	$18.2M	Sell	253,521 -173,173	-41%	-$24.1M	﹤0.01%	994
2023 Q4	$84.8M	Sell	426,694 -15,786	-4%	-$1.95M	0.01%	580
2023 Q3	$58.8M	Buy	442,480 +6,511	+1%	+$1.06M	0.01%	638
2023 Q2	$65.2M	Buy	435,969 +21,485	+5%	+$3.35M	0.01%	626
2023 Q1	$60.8M	Sell	414,484 -6,127	-1%	-$1.24M	0.01%	629
2022 Q4	$66.6M	Buy	420,611 +35,643	+9%	+$5.7M	0.01%	587
2022 Q3	$74.1M	Sell	384,968 -156,867	-29%	-$29.7M	0.01%	547
2022 Q2	$79.1M	Buy	541,835 +44,997	+9%	+$6M	0.01%	730
2022 Q1	$87.4M	Buy	496,838 +3,377	+0.7%	+$638K	0.01%	775
2021 Q4	$145M	Buy	493,461 +5,689	+1%	+$1.52M	0.01%	650
2021 Q3	$121M	Buy	487,772 +38,597	+9%	+$10.2M	0.01%	702
2021 Q2	$114M	Buy	449,175 +126,694	+39%	+$23.7M	0.01%	737
2021 Q1	$57.3M	Sell	322,481 -705	-0.2%	-$116K	0.01%	962
2020 Q4	$51.1M	Sell	323,186 -5,317	-2%	-$1.16M	0.01%	957
2020 Q3	$84.6M	Buy	328,503 +149,639	+84%	+$33.2M	0.01%	710
2020 Q2	$41.5M	Buy	178,864 +16,228	+10%	+$2.51M	0.01%	910
2020 Q1	$27.1M	Buy	162,636 +14,732	+10%	+$3.36M	﹤0.01%	971
2019 Q4	$31.9M	Buy	+147,904	New	+$27.2M	﹤0.01%	1047

Other funds holding RAPT